graph Evidence gap map comparisons
atezolizumab based treatmentnivolumab based treatment
atezolizumab plus cabozantinib nivolumab alone
Comparator:  vs cabozantinib;   vs everolimus; 
Risk of bias:  low;   some concerns;   high;  NA;